NASDAQIOVA

Business

Iovance gets FDA accelerated approval for advanced melanoma therapy (NASDAQ:IOVA)

Bet_Noire Iovance Biotherapeutics (NASDAQ:IOVA) has received FDA accelerated approval for its T-cell immunotherapy lifileucel, also known as Amtagvi, in the…

Read More »
Back to top button